…. Despite being needed in 80% of suspected cases following BDR, BPT access remains limited in Canada. Type-2 (T2) inflammatory biom…
All extracted treatments
Showing 601–660 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Articles mentioning treatments
7,227 articles · page 466 of 603…o treatment. Even with the adoption of optimisation techniques, biliary brushings remain suboptimal with sensitivity rates in the region of 60%.5…
…dulthood, with >10% developing severe visual impairment despite biologic therapy.…
…elucidated.Aim This study is a post hoc analysis of the CABANA (Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial.M…
…ulted in right cerebellar and lateral medullary infarct. During antiplatelet therapy, the left cerebellum infarct recurred on the seventh hospital d…
…hout present or past signs of joint swelling or present or past anti-rheumatic therapy. All participants underwent structured clinical and laboratory …
…diagnosis, true hypertension prevalence, and control and use of antihypertensive drugs in England.Design Annual, representative, nationwide Health Sur…
…rticularly Heidenhain variant of CJD. CSF samples were sent for RT-QUic which came back positive, confirming a diagnosis of CJD (likely…
…educe complication rates by reducing spinal inflammation. While anti-mycobacterial therapy is an important aspect of management, delay in its initiation d…
…tonin gene-related peptide monoclonal antibody, is approved for preventive migraine treatment in adults. The multicentre, parallel-group, Phase 3 SPACE study…
…and cons of each treatment. Those offered onabotulinumtoxinA or CGRP MAB, 70% chose onabotulinumtoxinA as their preferred treatment comp…
…neurological toxicity occurring in 50% of patients treated with CAR T-cell therapy. Advances in understanding its pathophysiology, recognition, an…